There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

Recent reviews have emphasized the need for a health equity agenda in genomics
research. To ensure that genomic discoveries can lead to improved health outcomes for all …

Background Genetic testing for risk of hereditary cancer can help patients to make important
decisions about prevention or early detection. US and UK studies show that people from …

PURPOSE Evidence-based guidelines recommend cascade genetic counseling and testing
for hereditary cancer syndromes, providing relatives the opportunity for early detection and …

BACKGROUND Breast cancer (BC) disparities may widen with genomic advances. The
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …

Background & Aims Multigene panels are commercially available tools for hereditary cancer
risk assessment that allow for next-generation sequencing of numerous genes in parallel …

Nearly 3% of the population carries genetic variants that lead to conditions that include
hereditary breast and ovarian cancer and Lynch syndrome. These pathogenic variants …

Purpose Racial disparities in BRCA1/2 testing have been documented, but causes of these
disparities are poorly understood. The study objective was to investigate whether the …

Triple-negative breast cancer (TNBC) is a very heterogeneous and aggressive breast
cancer subtype with a high risk of mortality, even if diagnosed early. The mainstay of early …

Background Breast cancer incidence is higher among black women than white women
before age 40 years, but higher among white women than black women after age 40 years …